|
[1]DONG CF,XIAO J,SHAN LB,et al.Combined acoustic radiation force impulse,aminotransferase to platelet ratio index and Forns index assessment for hepatic fibrosis grading in hepatitis B[J].World J Hepatol,2016,8(14):616-624.
|
|
[2]YAO J,CHANG L,YUAN L,et al.Nutrition status and small intestinal bacterial overgrowth in patients with virus-related cirrhosis[J].Asia Pac J Clin Nutr,2016,25(2):283-291.
|
|
[3]PENG CY,CHIEN RN,LIAW YF.Hepatitis B virus-related decompensated liver cirrhosis:benefits of antiviral therapy[J].J Hepatol,2012,57(2):442-450.
|
|
[4]ILOEJE UH,YANG HI,SU J,et al.Predicting cirrhosis risk based on the level of circulating hepatitis B viral load[J].Gastroenterology,2006,130(3):678-686.
|
|
[5]CHEN CJ,YANG HI,SU J,et al.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level[J].JAMA,2006,295(1):65-73.
|
|
[6]ROCHE B,SAMUEL D.Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation:A retrospective study[J].J Hepatol,2009,50(4):719-728.
|
|
[7]KUMADA T,TOYODA H,TADA T,et al.Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients:a propensity score analysis[J].J Hepatol,2013,58(3):427-433.
|
|
[8]ABU-AMARA M,FELD JJ.Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma?[J].Semin Liver Dis,2013,33(2):157-166.
|
|
[9]TU YY,CHEN HY,LIU XD,et al.Research progress in antiviral therapy for decompensated hepatitis B cirrhosis[J].J Clin Hepatol,2015,31(3):460-464.(in Chinese)涂燕云,陈海艳,刘旭东,等.乙型肝炎肝硬化失代偿期抗病毒治疗的研究进展[J].临床肝胆病杂志,2015,31(3):460-464.
|
|
[10] PU CW,LIU W,LI M,et al.Long term antiviral therapy for chronic hepatitis B can reverse liver cirrhosis[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition,2014,8(4):577-579.(in Chinese)蒲春文,刘威,李梅,等.慢性乙型肝炎的长期抗病毒治疗可逆转肝硬化[J/CD].中华实验和临床感染病杂志:电子版,2014,8(4):577-579.
|
|
[11]SCHIFF ER,LEE SS,CHAO YC,et al.Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B[J].Clin Gastroenterol Hepatol,2011,9(3):274-276.
|
|
[12]ZOUTENDIJK R,REIJNDERS JG,ZOULIM F,et al.Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis[J].Gut,2013,62(5):760-765.
|
|
[13]ZHANG W,LI QW,LIU YB.Evalution of quality of life and analysis on its correlation with TCM syndrome in patients of Chronic Hepatitis B[J].Chin J Integr Med,2009,15(1):30-33.
|
|
[14]YU Y,GONG R,MU Y,et al.Hepatitis B virus induces a novel inflammation network involving three inflammatory factors,IL-29,IL-8,and cyclooxygenase-2[J].J Immunol,2011,187(9):4844-4860.
|
|
[15] Chinese Society of Hepatology,Chinese Society of Infectious Diseases.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].Chin J Clin Infect Dis,2011,4(1):1-13.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].中华临床感染病杂志,2011,4(1):1-13.
|
|
[16]LAI JQ,LIU GA,PAN XN,et al.The ultrasonic performance and clinical efficacy of 64 patients with hepatitis B virus-related compensated cirrhosis with the treatment of entecavir combined with Fuzheng Huayu Capsule[J].J Pract Hepatol,2011,14(6):458-459.(in Chinese)赖江琼,刘国安,潘兴南,等.恩替卡韦联合扶正化瘀胶囊治疗64例乙型肝炎肝硬化超声表现及临床疗效分析[J].实用肝脏病杂志,2011,14(6):458-459.
|
|
[17]HONKOOP P,de MAN RA.Entecavir:a potent new antiviral drug for hepatitis B[J].Expert Opin Investig Drugs,2003,12(4):683-688.
|
|
[18]YAO GB,ZHANG DF,WANG BE,et al.A study of the dosage and efficacy of entecavir for treating hepatitis B virus[J].Chin J Hepatol,2005,13(7):484-487.(in Chinese)姚光弼,张定凤,王宝恩,等.恩替卡韦抗乙型肝炎病毒剂量和疗效的研究[J].中华肝脏病杂志,2005,13(7):484-487.
|
|
[19]SEIFER M,HAMATAKE RK,COLONNO RJ,et al.In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir[J].Antimicrob Agents Chemother,1998,42(12):3200-3208.
|
|
[20]ZHANG B,HU M,HUANG L,et al.Effect of Fuzheng Huayu capsule combined with Pegasys on genotype 1 hepatitis C fibrosis and cell apoptosis[J].Exp Ther Med,2014,8(4):1123-1126.
|
|
[21]GU J,ZHANG Q,XUE D,et al.A randomized controlled study of fuzheng huayu capsule for prevention of esophageal variceal bleeding in patients with liver cirrhosis[J].Evid Based Complement Alternat Med,2013,2013:534960.
|
|
[22]YU S,GUO Z,GUAN Y,et al.Combining ZHENG theory and high-throughput expression data to predict new effects of Chinese herbal formulae[J].Evid Based Complement Alternat Med,2012,2012:986427.
|
|
[23]LIU P,LIU C,XU LM,et al.Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B[J].World J Gastroenterol,1998,4(4):348-353.
|
|
[24]FAN RQ,SU CZ,ZHU GJ,et al.Therapeutic efficacy of entecavir combined with Fuzheng Huayu capsule in 73 cases of liver fibrosis in chronic hepatitis B[J].Chin J Gastroenterol Hepatol,2013,22(1):31-33.(in Chinese)范瑞琴,苏传真,朱刚剑,等.恩替卡韦联合扶正化瘀胶囊治疗慢性乙型肝炎肝纤维化73例疗效观察[J].胃肠病学和肝病学杂志,2013,22(1):31-33.
|
|
[25]WU LL.Efficacy of entecavir combined with fuzhenghuayu capsules in treatment of patients with hepatitis B related cirrhosis[J].Mod J Integr Tradit Chin West Med,2013,22(35):3952-3953.(in Chinese)吴龙龙.恩替卡韦联合扶正化瘀胶囊治疗慢性乙型肝炎肝纤维化疗效观察[J].现代中西医结合杂志,2013,22(35):3952-3953.
|
|
[26]BOSSA AS,SALEMI VM,RIBEIRO SP,et al.Plasma cytokine profile in tropical endomyocardial fibrosis:predominance of TNFa,IL-4 and IL-10[J].PLoS One,2014,9(10):e108984.
|
|
[27]BASINSKA K,MARYCZ K,'SIESZEK A,et al.The production and distribution of IL-6 and TNF-a in subcutaneous adipose tissue and their correlation with serum concentrations in Welsh ponies with equine metabolic syndrome[J].J Vet Sci,2015,16(1):113-120.
|
|
[28]LIU JX,XU B,LIU XX,et al.Correlation of IFN-γand IL-6levels produced by peripheral blood mononuclear cells and HBVDNA load in patients with chronic hepatitis B[J].J Clin Hepatol,2010,26(5):510-512.(in Chinese)刘家秀,徐彬,刘兴祥,等.慢性乙型肝炎患者HBV DNA载量与PMBC分泌IFN-γ、IL-6水平相关性研究[J].临床肝胆病杂志,2010,26(5):510-512.
|
|
[29]ZUO WZ,XU CM,SHEN LC.Changes in serum level of interleukin-32 and interleukin-6 in patients with chronic hepatitis B virus infection and its clinical significance[J].J Clin Hepatol,2011,27(4):408-413.(in Chinese)左维泽,许春梅,沈兰超.乙型肝炎患者血清白细胞介素-32、白细胞介素-6水平变化及临床意义[J].临床肝胆病杂志,2011,27(4):408-413.
|
|
[30]KADAM N,ACHARYA S,SHUKLA S,et al.Ascitic fluid high sensitive C-reactive protein(hs-CRP).A prognostic marker in cirrhosis with spontaneous bacterial peritonitis[J].J Clin Diagn Res,2016,10(4):20-24.
|
|
[31]ZHANG HX,LIU XD,WU HK.Effect of Fuzheng Huayu Capsules on inflammatory factors in patients with chronic hepatitis B cirrhosis[J].Chin J Integr Tradit West Med Liver Dis,2016,26(1):4-5.(in Chinese)张红星,刘旭,吴辉坤.扶正化瘀胶囊对慢性乙型肝炎肝硬化患者炎性因子的影响[J].中西医结合肝病杂志,2016,26(1):4-5.
|
DownLoad: